As next-generation sequencing (NGS) applications expand, researchers face growing pressure to generate accurate, uniform data from increasingly complex and low input samples.
Next-generation sequencing (NGS) has transformed genomic research and clinical diagnostics by enabling rapid, high-throughput analysis of genetic material. The application of NGS to formalin-fixed ...
Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...
A low DNA binding consumables range minimizes interactions between nucleic acids and plastic surfaces, supporting more ...
Shareef A. Nahas brings deep expertise in genomics and laboratory operations, with senior leadership experience at Rady Children’s Institute for Genomic Medicine, Genoptix (Novartis), and Ambry ...
Healthcare Asia Magazine on MSN
AI and genomics drive global NGS market to $29.5b by 2030
APAC is expected to be the fastest-growing market. The global next-generation sequencing (NGS) market is projected to grow from $14.94b in 2025 to $29.53b by 2030, registering a CAGR of 14.6%, ...
The Illumina NovaSeq X adds to Agilus Diagnostics’ molecular testing portfolio through high-throughput sequencing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results